|
This is in response to Jeff' post. If you look at the HERA trail percentage of those with her2+ disease in the New England Journal of Med., overwhelmingly, most her2+ were er, pr negative as opposed to other hormonal receptor sensitivity. This was a large study, so I think this is significant and says something about the strong correlate between er, pr negative and Her2+.
__________________
Robin
2002- dx her2 positive DCIS/bc TX Mast, herceptin chemo
|